ACUTE EFFECTS OF BENZODIAZEPINES ON OPERANT-BEHAVIOR AND IN-VIVO RECEPTOR-BINDING IN MICE

被引:14
作者
BURKE, TF [1 ]
MILLER, LG [1 ]
MOERSCHBAECHER, JM [1 ]
机构
[1] LOUISIANA STATE UNIV,MED CTR,DEPT PHARMACOL,NEW ORLEANS,LA 70112
关键词
ALPRAZOLAM; BENZODIAZEPINES; DIFFERENTIAL REINFORCEMENT OF LOW RESPONSE RATE; FIXED-INTERVAL; FIXED-RATIO; FLUMAZENIL; GABA(A)-BENZODIAZEPINE RECEPTOR COMPLEX; IN VIVO BINDING; LORAZEPAM; MICE; OPERANT BEHAVIOR;
D O I
10.1016/0091-3057(94)90500-2
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Lorazepam and alprazolam produced dose-dependent decreases in the rate of fixed-ratio (FR) 20 schedules of food presentation in which either a nose-poke or a lever-press defined the operant and under a fixed-interval (FI) 2-min lever-press schedule of food presentation. In contrast, under FI 2-min and differential reinforcement of low response rate (DRL) 20-s schedules of nose-poke responding for food, intermediate doses of alprazolam produced increases in response rate. Lorazepam, however, only decreased overall response rates under the FI schedule and produced some increases in responding under the DRL schedule. Acute in vivo benzodiazepine receptor binding experiments showed that low to intermediate doses of alprazolam produced significant increases in the binding of [H-3]flumazenil in all brain areas tested, while lorazepam produced increases in the brain stem only. The acute effects on binding produced by both drugs were positively and significantly correlated with their acute effects on response rate only under the FR lever-press procedure. These results indicate that the effects of benzodiazepines on in vivo binding may be related to their effects on FR lever-press responding.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 32 条
[1]  
BROCKLEHURST C, 1987, FED PROC, V46, P1131
[2]   USE OF DRL IN DIFFERENTIATING ANXIOLYTIC AND NEUROLEPTIC PROPERTIES OF CNS DRUGS [J].
CANON, JG ;
LIPPA, AS .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1977, 6 (05) :591-593
[3]  
CIRAULO CA, 1986, J CLIN PHARMACOL, V4, P292
[4]   BEHAVIORAL EFFECTS OF BENZODIAZEPINES [J].
DANTZER, R .
BIOBEHAVIORAL REVIEWS, 1977, 1 (02) :71-86
[5]  
DEVIA C, 1987, FED PROC, V46, P1131
[6]  
DEWS PB, 1977, ADV BEHAV PHARMACOL, P167
[7]   MULTIPLE BENZODIAZEPINE RECEPTORS - NO REASON FOR ANXIETY [J].
DOBLE, A ;
MARTIN, IL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (02) :76-81
[8]   INVIVO RECEPTOR OCCUPATION BY BENZODIAZEPINES AND CORRELATION WITH THE PHARMACOLOGICAL EFFECT [J].
DUKA, T ;
HOLLT, V ;
HERZ, A .
BRAIN RESEARCH, 1979, 179 (01) :147-156
[9]   ALPRAZOLAM COMPARED TO AMITRIPTYLINE IN THE TREATMENT OF MAJOR DEPRESSION [J].
ERIKSSON, B ;
NAGY, A ;
STARMARK, JE ;
THELANDER, U .
ACTA PSYCHIATRICA SCANDINAVICA, 1987, 75 (06) :656-663
[10]   DOES ALPRAZOLAM, IN CONTRAST TO DIAZEPAM, ACTIVATE ALPHA-2-ADRENOCEPTORS INVOLVED IN THE REGULATION OF RAT GROWTH-HORMONE SECRETION [J].
ERIKSSON, E ;
CARLSSON, M ;
NILSSON, C ;
SODERPALM, B .
LIFE SCIENCES, 1986, 38 (16) :1491-1498